You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表现》先声药业(02096.HK)暗盘高开5.8%报14.5元 现倒跌14%
阿思达克 10-23 16:32
根据辉立交易平台显示,下周二(27日)挂牌的先声药业(02096.HK)暗盘高开5.8%报14.5元欠承接,掉头回落至11元,现造11.74元,较上市价13.7元,低14.3%,成交522万股。

先声是内地药品研发、生产和商业化的公司,目前主要从事仿制药业务。公司在以下专注战略性治疗领域拥有多元化的产品组合,分别有肿瘤、中枢神经系统及自身免疫疾病。先声曾於2007年作为当时中国第一家生物和化学制药公司登陆纽约证券交易所,随後於2013年将公司私有化。今次来港上市合共发售近2.61亿股,并已引入包括Hillhouse Capital、红土及高新等7名基石投资者,合共认购1.07亿股;10%公开发售获逾588倍超购,已重启回拨机制占比增至50%,认购一手中签率仅5%;股份以招股范围(12.1-13.7元)上限定价,料集资净额约33.92亿元,主要用於持续研发战略重点治疗领域中选定的在研产品、加强集团销售和营销能力、未来几年投资医药或生物技术领域公司及还债等。上市联席保荐人分别为大摩及中金。(sz/u)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account